Literature DB >> 33567687

Sex Differences in the Effects of COPD on Incidence and Outcomes of Patients Hospitalized with ST and Non-ST Elevation Myocardial Infarction: A Population-Based Matched-Pair Analysis in Spain (2016-2018).

Javier de-Miguel-Diez1,2, Rodrigo Jiménez-García3, Valentín Hernandez-Barrera4, Zichen Ji1, José María de Miguel-Yanes5, Marta López-Herranz6, Ana López-de-Andrés3.   

Abstract

We aimed to compare the incidence, clinical characteristics, and outcomes of patients admitted with myocardial infarction (MI), whether ST elevation MI (STEMI) or non-ST elevation MI (NSTEMI), according to the presence of chronic obstructive pulmonary disease (COPD), and to identify variables associated with in-hospital mortality (IHM). We selected all patients with MI (aged ≥40 years) included in the Spanish National Hospital Discharge Database (2016-2018). We matched each patient suffering COPD with a non-COPD patient with identical age, sex, type of MI, and year of hospitalization. We identified 109,759 men and 44,589 women with MI. The MI incidence was higher in COPD patients (incident rate ratio (IRR) 1.32; 95% confidence interval (CI) 1.29-1.35). Men with COPD had higher incidence of STEMI and NSTEMI than women with COPD. After matching, COPD men had a higher IHM than non-COPD men, but no differences were found among women. The probability of dying was higher among COPD men with STEMI in comparison with NSTEMI (odds ratio (OR) 2.33; 95% CI 1.96-2.77), with this risk being higher among COPD women (OR 2.63; 95% CI 1.75-3.95). Suffering COPD increased the IHM after an MI in men (OR 1.14; 95% CI 1.03-1.27), but no differences were found in women. COPD women had a higher IHM than men (OR 1.19; 95% CI 1.01-1.39). We conclude that MI incidence was higher in COPD patients. IHM was higher in COPD men than in those without COPD, but no differences were found among women. Among COPD patients, STEMI was more lethal than NSTEMI. Suffering COPD increased the IHM after MI among men. Women with COPD had a significantly higher probability of dying in the hospital than COPD men.

Entities:  

Keywords:  COPD; NSTEMI; STEMI; in-hospital mortality; incidence; sex differences

Year:  2021        PMID: 33567687      PMCID: PMC7914459          DOI: 10.3390/jcm10040652

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  33 in total

1.  Chronic obstructive pulmonary disease after myocardial infarction in the community.

Authors:  Francesca Bursi; Robert Vassallo; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

2.  Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction: The SILVER-AMI Study.

Authors:  Michael G Nanna; Alexandra M Hajduk; Harlan M Krumholz; Terrence E Murphy; Rachel P Dreyer; Karen P Alexander; Mary Geda; Sui Tsang; Francine K Welty; Basmah Safdar; Dharshan K Lakshminarayan; Sarwat I Chaudhry; John A Dodson
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-10-14

Review 3.  COPD and acute myocardial infarction.

Authors:  Laurien Goedemans; Jeroen J Bax; Victoria Delgado
Journal:  Eur Respir Rev       Date:  2020-06-23

4.  Two-year mortality and its determinants following acute myocardial infarction in Trinidad and Tobago.

Authors:  C N Thomas; G Titus; D Williams; D Simeon; P Pitt-Miller
Journal:  West Indian Med J       Date:  2000-06       Impact factor: 0.171

5.  Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.

Authors:  Suellen M Curkendall; Cynthia DeLuise; Judith K Jones; Stephan Lanes; Mary Rose Stang; Earl Goehring; Dewei She
Journal:  Ann Epidemiol       Date:  2005-07-21       Impact factor: 3.797

6.  Prevalence and predictors associated with in-hospital mortality in acute ST segment elevation myocardial infarction after reperfusion therapy in developing country.

Authors:  Chorchana Wichian; Thotsaporn Morasert; Thanapon Nilmoje; Ply Chichareon
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

Review 7.  Cardiovascular disease in COPD: mechanisms.

Authors:  John D Maclay; William MacNee
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

8.  Prevalence and Determinants of COPD in Spain: EPISCAN II.

Authors:  Joan B Soriano; Inmaculada Alfageme; Marc Miravitlles; Pilar de Lucas; Juan José Soler-Cataluña; Francisco García-Río; Ciro Casanova; José Miguel Rodríguez González-Moro; Borja G Cosío; Guadalupe Sánchez; Julio Ancochea
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-09-17

Review 9.  Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.

Authors:  Kieran J Rothnie; Ruoling Yan; Liam Smeeth; Jennifer K Quint
Journal:  BMJ Open       Date:  2015-09-11       Impact factor: 2.692

10.  Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data.

Authors:  Amit Kaura; Jonathan A C Sterne; Adam Trickey; Sam Abbott; Abdulrahim Mulla; Benjamin Glampson; Vasileios Panoulas; Jim Davies; Kerrie Woods; Joe Omigie; Anoop D Shah; Keith M Channon; Jonathan N Weber; Mark R Thursz; Paul Elliott; Harry Hemingway; Bryan Williams; Folkert W Asselbergs; Michael O'Sullivan; Graham M Lord; Narbeh Melikian; Thomas Johnson; Darrel P Francis; Ajay M Shah; Divaka Perera; Rajesh Kharbanda; Riyaz S Patel; Jamil Mayet
Journal:  Lancet       Date:  2020-08-29       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.